#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Lip and/or oral cavity cancer Ovarian epithelial cancer Waldenstrom's macroglobulinaemia recurrent Osteosarcoma metastatic Brain injury Cholestatic pruritus X-linked lymphoproliferative syndrome Small cell lung cancer Granulomatosis with polyangiitis Immunoglobulin G4 related disease Cerebellar ataxia Chronic myeloid leukaemia Cardiac failure acute Staphylococcal infection Solitary fibrous tumour More trials…

    Learn about Rare Diseases

    Lymphangiosarcoma – Treatment Marfan’s syndrome – Diagnostics X-linked lymphoproliferative syndrome – Basic Information Fragile X syndrome – Diagnostics Aicardi-Goutieres syndrome – Diagnostics Glomerulonephritis membranoproliferative – Treatment Synovial sarcoma – Trials in Disease Fragile X syndrome – Life with Disease Antithrombin III deficiency – Life with Disease Extranodal marginal zone B-cell lymphoma (MALT type) – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dabrafenib Mesylate Metoprolol Tartrate Sodium Hydrogen Carbonate Dexpanthenol Promethazine Hydrochloride Thiocolchicoside Jab-21822 ORX750 Alogliptin Elenestinib Phosphate TETRODOTOXIN Cetrimide Acemetacin Eltrombopag D5-Ethyl-Beta-D-Glucuronide Gad20-209-Fsp-A2 ILOPROST Zofenopril Calcium Aliskiren Blomia Tropicalis More therapies…

    Learn about Your Condition

    Implantation complication Malignant glioma Drug eruption Rheumatoid arthritis Otitis media Upper limb fracture Depression Castleman's disease Neonatal asphyxia Epileptic encephalopathy Erosive oesophagitis Tardive dyskinesia Procedural pain Diabetic gastroparesis Macular telangiectasia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Oesophageal carcinoma

  • Study on AZD0901 and Drug Combination for Patients with Advanced Gastric, Gastroesophageal, and Pancreatic Cancers Expressing Claudin 18.2

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Biliary neoplasm
    • Gastric cancer
    • Oesophageal carcinoma
    Investigated Drugs:
    • Azd0901
    • Irinotecan
    • Fluorouracil
    Poland Spain

  • Study on Changes in [18F]F-AraG Uptake After Radiotherapy in Patients with Non-Small Cell Lung Cancer, Melanoma, Breast Cancer, and Esophageal Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    • Oesophageal carcinoma
    • Breast cancer
    Investigated Drugs:
    • Nelarabine
    The Netherlands

  • Study of Avelumab with Chemotherapy for Patients with Resectable Stomach or Gastroesophageal Junction Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastric cancer
    • Oesophageal carcinoma
    Investigated Drugs:
    • Avelumab
    • Calcium Folinate
    • Docetaxel
    Spain

  • Study on Preventing Infections After Esophageal Cancer Surgery Using Colistin Sulfate, Tobramycin, and Amphotericin B in Patients with Resectable Esophageal Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Oesophageal carcinoma
    Investigated Drugs:
    • Nystatin
    • Tobramycin
    • Colistin Sulfate
    Belgium The Netherlands

  • Study to Determine the Best Dose of Zongertinib with Trastuzumab Deruxtecan or Trastuzumab Emtansine for Patients with Advanced HER2+ Metastatic Cancer

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Calcium Folinate
    • Capecitabine
    • Fluorouracil
    Belgium France Germany Italy Spain

  • Study of Oxaliplatin, Nivolumab, and Trifluridine/Tipiracil for Patients with Advanced Gastric, Esophageal, or Gastroesophageal Junction Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastrooesophageal cancer
    • Gastric cancer recurrent
    • Gastric cancer
    Investigated Drugs:
    • Levoleucovorin
    • Tipiracil Hydrochloride
    • Tipiracil
    France
Previous Page
1 2 3 4 … 6
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!